Posted inEuronext
ABL Diagnostics to acquire TEXCELL
PARIS: ABL Diagnostics, a molecular diagnostics and healthcare software company listed on Euronext Paris, has been selected by the Évry Commercial Court to acquire the assets and operations of TEXCELL, the company announced.…









